Literature DB >> 32986019

Oncogene-induced DNA damage: cyclic AMP steps into the ring.

James A Fagin1,2, John H Petrini3.   

Abstract

Growth hormone-secreting (GH-secreting) pituitary tumors are driven by oncogenes that induce cAMP signaling. In this issue of the JCI, Ben-Shlomo et al. performed a whole-exome study of pituitary adenomas. GH-secreting tumors had a high frequency of whole chromosome or chromosome arm copy number alterations and were associated with an increase in the tumor protein p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1, which are findings consistent with induction of a response to DNA damage. Further, treatment of mouse pituitary cells with cAMP pathway agonists in vitro and in vivo elicited biomarkers of DNA replication stress or double-strand breaks. The findings of Ben Shlomo et al. indicate that oncoproteins that drive constitutively high cAMP signaling pathway output in susceptible cell types can elicit DNA replication stress and may promote genomic instability.

Entities:  

Year:  2020        PMID: 32986019      PMCID: PMC7598063          DOI: 10.1172/JCI142237

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  DNA replication-dependent nuclear dynamics of the Mre11 complex.

Authors:  Olga K Mirzoeva; John H J Petrini
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

2.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

Review 3.  R-Loops as Cellular Regulators and Genomic Threats.

Authors:  Madzia P Crossley; Michael Bocek; Karlene A Cimprich
Journal:  Mol Cell       Date:  2019-02-07       Impact factor: 17.970

4.  A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability.

Authors:  Katerina D Fagan-Solis; Dennis A Simpson; Rashmi J Kumar; Luciano G Martelotto; Lisle E Mose; Naim U Rashid; Alice Y Ho; Simon N Powell; Y Hannah Wen; Joel S Parker; Jorge S Reis-Filho; John H J Petrini; Gaorav P Gupta
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

Review 5.  R Loops: From Physiological to Pathological Roles.

Authors:  Tatiana García-Muse; Andrés Aguilera
Journal:  Cell       Date:  2019-10-10       Impact factor: 41.582

6.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

Review 7.  PDE4 subtypes in cancer.

Authors:  Samuel Hsien Lai; Guston Zervoudakis; Jesse Chou; Mark E Gurney; Kelly M Quesnelle
Journal:  Oncogene       Date:  2020-03-20       Impact factor: 9.867

8.  Carcinoma of endocrine organs: results of the RARECARE project.

Authors:  Jan Maarten van der Zwan; Sandra Mallone; Boukje van Dijk; Magdalena Bielska-Lasota; Renée Otter; Roberto Foschi; Eric Baudin; Thera P Links
Journal:  Eur J Cancer       Date:  2012-02-21       Impact factor: 9.162

9.  AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.

Authors:  I Tuominen; E Heliövaara; A Raitila; M-R Rautiainen; M Mehine; R Katainen; I Donner; V Aittomäki; H J Lehtonen; M Ahlsten; L Kivipelto; C Schalin-Jäntti; J Arola; S Hautaniemi; A Karhu
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867

10.  The genome-wide mutational landscape of pituitary adenomas.

Authors:  Zhi-Jian Song; Zachary J Reitman; Zeng-Yi Ma; Jian-Hua Chen; Qi-Lin Zhang; Xue-Fei Shou; Chuan-Xin Huang; Yong-Fei Wang; Shi-Qi Li; Ying Mao; Liang-Fu Zhou; Bao-Feng Lian; Hai Yan; Yong-Yong Shi; Yao Zhao
Journal:  Cell Res       Date:  2016-09-27       Impact factor: 25.617

View more
  3 in total

1.  Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor.

Authors:  Meghana Manjunath; Sai Swaroop; Sai Sanwid Pradhan; Raksha Rao K; Raghunandan Mahadeva; Venketesh Sivaramakrishnan; Bibha Choudhary
Journal:  Genes (Basel)       Date:  2022-07-06       Impact factor: 4.141

Review 2.  Genetic and Epigenetic Pathogenesis of Acromegaly.

Authors:  Masaaki Yamamoto; Yutaka Takahashi
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

3.  Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma.

Authors:  Mingjun Xu; Ting Ma; Shanping Shi; Jingjun Xing; Yang Xi
Journal:  Life (Basel)       Date:  2021-11-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.